
-
What's not being discussed at G7 as Trump shapes agenda
-
UK apologises to thousands of grooming victims as it toughens law
-
Iran state TV briefly knocked off air by strike after missiles kill 11 in Israel
-
Trump urges Iran to talk as G7 looks for common ground
-
Canada wildfire near Vancouver contained
-
Four Atletico ultras get suspended jail for Vinicius effigy
-
England's top women's league to expand to 14 teams
-
Oil prices drop, stocks climb as Iran-Israel war fears ease
-
UN refugee agency says will shed 3,500 jobs due to funding cuts
-
US moves to protect all species of pangolin, world's most trafficked mammal
-
Kneecap 'unfazed' by legal problems, says friend and director
-
Electric fences, drones, dogs protect G7 leaders from bear attack
-
The name's Metreweli... Who is UK MI6's first woman chief?
-
Oil prices fall, stocks rise as Iran-Israel war fears ease
-
Fighter jets, refuelling aircraft, frigate: UK assets in Mideast
-
Iranian Nobel laureates, Cannes winner urge halt to Iran-Israel conflict
-
Struggling Gucci owner's shares soar over new CEO reports
-
Khamenei, Iran's political survivor, faces ultimate test
-
Ireland prepares to excavate 'mass grave' at mother and baby home
-
France shuts Israeli weapons booths at Paris Air Show
-
Iran and Israel exchange deadly strikes in spiralling air war
-
Ex-England captain Farrell rejoins Saracens from Racing 92
-
UN slashes global aid plan over 'deepest funding cuts ever'
-
Sri Lanka's Mathews hails 'dream run' in final Test against Bangladesh
-
Former England captain Farrell rejoins Saracens from Racing 92
-
Olympic champ Ingebrigtsen's father acquitted of abusing son
-
Maria climbs 43 places in WTA rankings after Queen's win
-
Iran hits Israel with deadly missile onslaught
-
German court jails Syrian 'torture' doctor for life
-
Oil prices fall even as Israel-Iran strikes extend into fourth day
-
Scientists track egret's 38-hour flight from Australia to PNG
-
Los Angeles curfew to continue for 'couple more days': mayor
-
Iran hits Tel Aviv after overnight Israeli strikes on Tehran
-
China factory output slows but consumption offers bright spot
-
G7 confronts Israel-Iran crisis as Trump dominates summit
-
Relatives wait for remains after Air India crash
-
China factory output slumps but consumption offers bright spot
-
Record-breaking Japan striker 'King Kazu' plays at 58
-
Trump lands in Canada as G7 confronts Israel-Iran crisis
-
Oil prices rise further as Israel-Iran extends into fourth day
-
Olympic champ Ingebrigtsen's father set for abuse trial verdict
-
German court to rule in case of Syrian 'torture' doctor
-
Trump orders deportation drive targeting Democratic cities
-
Spaun creates his magic moment to win first major at US Open
-
Royal Ascot battling 'headwinds' to secure foreign aces: racing director
-
Spaun wins US Open for first major title with late birdie binge
-
Israel pounds Iran, Tehran hits back with missiles
-
'Thin' chance against Chelsea but nothing to lose: LAFC's Lloris
-
PSG cruise over Atletico, Bayern thrash Auckland at Club World Cup
-
G7 protests hit Calgary with leaders far away

Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN